| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |